Severe asthma and cystic fibrosis: Overlapping phenotypes?

References

• Gershon AS, Guan J, Wang C, To T. Trends in asthma prevalence and incidence in Ontario, Canada, 1996–2005: a population study. Am J Epidemiol. 2010;172(6):728–736.
   PubMed Web of Science ®Google Scholar
• Chanez P, Wenzel SE, Anderson GP. Severe asthma in adults: what are the important questions?. J Allergy Clin Immunol. 2007;119(6):1337–1348.
   PubMed Web of Science ®Google Scholar
• Fahy J, Irvin C, Peters SP, Wenzel SE, Spector S, Szefler SJ. Proceedings of the ATS Workshop on Refractory Asthma. Am J Respir Crit Care Med. 2000;162(6):2341–2351.
   PubMedGoogle Scholar
• FitzGerald JM, Lemiere C, Lougheed MD, et al. Recognition and management of severe asthma: a Canadian Thoracic Society Position Statement. Canadian J Respir Crit Care Sleep Med. 2017; 1(4):199–221.
   Web of Science ®Google Scholar
• Balfour-Lynn IM. Asthma in cystic fibrosis. J R Soc Med 2003;96(Suppl. 43):30–34.
   Google Scholar
• Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet. 1998;351(9120):1911–1913.
   Web of Science ®Google Scholar
• Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A. Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion. J Allergy Clin Immunol. 2001;107(5):818–823.
   Web of Science ®Google Scholar
• De Boeck K, Vermeulen F, Dupont L. The diagnosis of cystic fibrosis. Presse Med. 2017;46(6 Pt 2):e97–e108.
   PubMed Web of Science ®Google Scholar
• Bombieri C, Claustres M, De Boeck K, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros. 2011;10:S86–S102.
   PubMed Web of Science ®Google Scholar
• Awasthi S, Maurya N, Agarwal S, Dixit P, Muthuswamy S, Singh S. Association of CFTR gene mutation with bronchial asthma and its severity in Indian children: a case-control study. Ann Hum Biol. 2012;39(2):113–121.
   PubMed Web of Science ®Google Scholar
• Von Mutius E, Sears MR. Risk factors for development of asthma. Eur Respir Mon. 2003;8:57–73.
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373.
   PubMed Web of Science ®Google Scholar
• Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis. Nat Med. 1995;1(7):703–705.
   Web of Science ®Google Scholar
• Mennie M, Gilfillan A, Brock DJ, Liston WA. Heterozygotes for the delta DF508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med. 1995;1(10):978–979.
   Web of Science ®Google Scholar
• Lowenfels AB, Maisonneuve P, Palys B, Schoni MH, Redemann B. Delta F508 heterozygosity and asthma. Lancet. 1998;352(9132):985–987.
   Google Scholar
• Kauffmann F, Chomel JC, Kitzis A, Feingold J, Group o. b o t EGEA Co-o. δF508 heterozygosity and asthma. Lancet. 1998;352(9132):986–987.
   Google Scholar
• de Cid R, Chomel JC, Lazaro C, et al. CFTR and asthma in the French EGEA study. Eur J Hum Genet. 2001;9(1):67–69.
   Web of Science ®Google Scholar
• Munthe-Kaas MC, Lodrup Carlsen KC, Carlsen KH, et al. CFTR gene mutations and asthma in the Norwegian Environment and Childhood Asthma study. Respir Med. 2006;100(12):2121–2128.
   Web of Science ®Google Scholar
• Douros K, Loukou I, Doudounakis S, Tzetis M, Priftis KN, Kanavakis E. Asthma and pulmonary function abnormalities in heterozygotes for cystic fibrosis transmembrane regulator gene mutations. Int J Clin Exp Med 2008;1:345–349.
   PubMed Web of Science ®Google Scholar
• Lougheed D, Lemiere C, Ducharme FM, et al. Canadian Thoracic Society 2012 guideline update: Diagnosis and management of asthma in preschoolers, children and adults. Can Respir J. 2012;19(2):127.
   PubMed Web of Science ®Google Scholar
• Schulz A, Tümmler B. Non-allergic asthma as a CFTR-related disorder. J Cyst Fibros. 2016;15(5):641–644.
   Web of Science ®Google Scholar
• Knutsen AP, Slavin RG. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol. 2011; 2011:1.
   Google Scholar
• CFTR2 Clinical and Functional Translation of CFTR. 2011; https://www.cftr2.org/.
   Google Scholar
• Collaco JM, Blackman SM, Raraigh KS, et al. Sources of variation in sweat chloride measurements in cystic fibrosis. Am J Respir Crit Care Med. 2016;194(11):1375–1382.
   Web of Science ®Google Scholar
• Ooi CY, Dupuis A, Ellis L, et al. Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis? Thorax. 2014;69(3):254–260.
   PubMed Web of Science ®Google Scholar
• Bombieri C, Benetazzo M, Saccomani A, et al. Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease. Hum Genet. 1998;103(6):718–722.
   Web of Science ®Google Scholar
• Casals T, De-Gracia J, Gallego M, et al. Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations? Clin Genet. 2004;65(6):490–495.
   Web of Science ®Google Scholar
• Coste A, Girodon E, Louis S, et al. Atypical sinusitis in adults must lead to looking for cystic fibrosis and primary ciliary dyskinesia. Laryngoscope. 2004;114(5):839–843.
   Web of Science ®Google Scholar
• Divac A, Nikolic A, Mitic-Milikic M, et al. CFTR mutations and polymorphisms in adults with disseminated bronchiectasis: a controversial issue. Thorax. 2005;60(1):85.
   Web of Science ®Google Scholar
• Girodon E, Cazeneuve C, Lebargy F, et al. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet. 1997;5(3):149–155.
   Web of Science ®Google Scholar
• Tzetis M, Efthymiadou A, Strofalis S, et al. CFTR gene mutations-including three novel nucleotide substitutions-and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet. 2001;108(3):216–221.
   Web of Science ®Google Scholar